new Glioblastoma treatment attacks brain tumors from multiple angles
On Nov. 12, 2024, researchers from the University of Basel and University Hospital Basel announced they had developed…
4-strain meningococcal vaccine tied to reduction in invasive meningitis cases, deaths
On Nov. 7, 2024, researchers reported that Implementation of routine immunization of U.S. adolescents with the quadrivalent (four-strain)…
Alzheimer’s and alcohol use disorder share similar gene expression patterns
On Nov. 5, 2024, Scripps research scientists reported they have shown that Alzheimer’s and alcohol use disorder (AUD)…
chronic wasting disease reported in Wyoming deer and elk
On Nov. 4, 2024, the Wyoming Game and Fish Department announced that it had confirmed the presence of…
Exposure to certain pollution sources harms children’s learning and memory, USC study shows
On Oct. 31, 2024, a University of Southern California (USC) study involving 8,500 children from across the country…
Large-scale study of brain volume found genetic links to Parkinson’s disease and ADHD
On Oct. 21, 2024, in one of the largest-ever studies of DNA and brain volume, researchers announced they…
Increased autism risk linked to Y chromosome, Geisinger study found
On Oct. 17, 2024, Geisinger announced results of a study that showed increased risk for autism appears to…
Doctors Discovered New Medical Condition Unique to Breakdancers
On Oct. 16, 2024, a researchers at Copenhagen University Hospital reported in a medical case report that a…
Human-Specific Genes Revealed Link Between Brain Growth and Autism
On Oct. 14, 2024, researchers have found a link between two human-specific genes and the gene SYNGAP1, a…
Lundbeck to acquire Longboard Pharmaceuticals for $2.6 billion
On Oct. 14, 2024, Lundbeck and Longboard Pharmaceuticals announced an agreement for Lundbeck to acquire Longboard for payment…
Neuroscientists revealed Integrated multimodal cell atlas of Alzheimer’s disease
On Oct, 14, 2024, a team of researchers from the Allen Institute of Brain Science and the University…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science News | Neurology | NIH | Non-Profit Research | Therapeutics | Vaccine
Study Found Persistent Infection Could Explain Long COVID in Some People
On Oct. 9, 2024, researchers from Brigham and Women’s Hospital found that people with wide-ranging long COVID symptoms…
Brain’s waste-clearance pathways revealed for the first time
On Oct. 9, 2024, scientists from Oregon Health & Science University (OHSU) released a study that used imaging…
Mental and health problems concentrated in 20% of the population
On Oct. 1, 2024, a study by the University of Amsterdam and the Trimbos Institute showed that 20%…
Risk of Dementia Diagnosis After Injurious Falls in Older Adults
On Sept. 30, 2024, a research team reported that emerging evidence suggested that mild cognitive impairment, which is…
Amneal Launched CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules for Treatment of Parkinson’s Disease
On Sept. 30, 2024, Amneal Pharmaceuticals announced that it had launched CREXONT ® (carbidopa and levodopa) extended-release capsules…
Biotechnology | COVID-19 | Diagnostics | Life Science News | Medical Device | Neurology | Therapeutics | Vaccine
Brain Scans revealed changes from Long COVID Fatigue
On Sept. 27, 2024, a study that evaluated the structural and functional connectivity correlates of fatigue in post-COVID…
Biotechnology | Diagnostics | Disease | Life Science News | Neurology | Non-Profit Research | Therapeutics
New mutation linked to early-onset Parkinsonism
On Sept. 26. 2024, a team of scientists led by Prof. Patrik Verstreken at the VIB-KU Leuven Center…
FDA Approved Drug with New Mechanism of Action for Treatment of Schizophrenia
On Sept. 26, 2024, the U.S. Food and Drug Administration (FDA) approved Bristol-Myers Squibb’s Cobenfy (xanomeline and trospium…
Pig’s Brain Revived almost an Hour After death
On Sept. 19, 2024, scientists from Sun Yat-Sen University in China announced they had revived a pig’s brain…
Biology | Biotechnology | Diagnostics | Disease | Life Science News | Medicine | Neurology | Non-Profit Research | Therapeutics
landmark UT Health San Antonio study found genetic risk-factor overlap between Alzheimer’s disease, and dementias
On Sept. 17, 2024, in landmark research, scientists at The University of Texas Health Science Center at San…
Biotechnology | Disease | Genomics | Life Science News | Neurology | Non-Profit Research | Therapeutics
University of Copenhagen researchers discovered longevity gene
On Sep. 4, 2024, researchers at the University of Copenhagen announced the discovery of a gene that has…
Biotechnology | Diagnostics | Disease | Life Science News | Neurology | Non-Profit Research | Therapeutics
Study Showed Over 10% of Medicare Beneficiaries Have Diagnoses Indicating Dementia
On Sept. 3, 2024, researchers at NORC at the University of Chicago and George Washington University’s Milken Institute…
Biotechnology | Diagnostics | Disease | Life Science News | Neurology | Non-Profit Research | Therapeutics
CIRM Awarded $67.5 Million to Address Neuropsychiatric Diseases
On Aug. 30, 2024, the California Institute for Regenerative Medicine (CIRM) approved $67.5 million to support five projects…
New Hampshire reported fatality from Eastern Equine Encephalitis Virus
On Aug. 27, 2024, the New Hampshire Department of Health and Human Services (DHHS) identified an adult who…
Study found no link between migraine and Parkinson’s disease
On Aug. 21, 2024, Contrary to previous research, a new study of female participants finds no link between…
Lilly opened state-of-the-art research and development center in the Boston Seaport
On Aug. 13, 2024, Eli Lilly announced the opening of the Lilly Seaport Innovation Center (LSC), a research…
FDA Approved Drug Targeting Johns Hopkins-Discovered Brain Cancer Gene Mutation
On Aug. 6, 2024, the U.S. Food and Drug Administration (FDA) announced it had approved vorasidenib (Voranigo, Servier…
the Lancet standing Commission Report: Dementia prevention, intervention, and care released
On Jul. 31, 2024, the Lancet Standing Commission released its 2024 Dementia prevention, intervention, and care report that…
Cannabinoid CBG reduced anxiety and stress in first human clinical trial
On Jul. 31, 2024, researchers at Washington State University (WSU) announced that the cannabigerol (CBG) effectively reduced anxiety…